Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOBQ | Preferred Stock Series G | Award | -301K | -8.83% | 3.1M | Dec 15, 2023 | Common Stock | 3.01M | $0.50 | Direct | F1, F2 | ||
transaction | MOBQ | Preferred Stock Series H | Disposed to Issuer | +752K | +10.96% | 7.62M | Dec 15, 2023 | Common Stock | 7.52M | $0.20 | Direct | F1, F2 | ||
transaction | MOBQ | Common stock options | Award | +100K | +1.31% | 7.72M | Dec 19, 2023 | Common Stock | 100K | $0.20 | Direct | F2 |
Id | Content |
---|---|
F1 | Not applicable. |
F2 | The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust. Salkind and the trust exchanged Series G preferred stock for series H preferred Stock with an issue value of $1,503,495. |